Abstracts of the Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, Paris, France. Eur J Heart Failure 2017; May; 29 April - 2 May 2017
Sato N, Takahashi W, Hirayama A, et al. Multicenter, randomized, double-blinded, placebo-controlled phase II study of serelaxin in japanese patients with acute heart failure. Circulation J 2015; 79(6): 1237-47.
Garvin R, Burns A. Serum relaxin levels in subjects with multiple sclerosis. Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia 2016; 121(1): 51-9.
Teerlink JR. RELAX-AHF-2: Serelaxin does not reduce risk for CV death worsening HF 2017.
Sonaglia F, Milia P, Caserio M, et al. Efficacy and safety of oral porcine relaxin (pRLX) in adjunct to physical exercise in the treatment of peripheral arterial disease (PAD). Italian J Anatomy Embryol 2013; 118(1 Suppl): 84-91.